stoxline Quote Chart Rank Option Currency Glossary
  
Agilent Technologies, Inc. (A)
130.57  -2.59 (-1.95%)    06-13 16:00
Open: 132.59
High: 133
Volume: 2,555,434
  
Pre. Close: 133.16
Low: 130.04
Market Cap: 38,095(M)
Technical analysis
2024-06-13 4:41:18 PM
Short term     
Mid term     
Targets 6-month :  168.04 1-year :  181.44
Resists First :  143.87 Second :  155.35
Pivot price 136.48
Supports First :  125.3 Second :  104.24
MAs MA(5) :  132.36 MA(20) :  140.84
MA(100) :  139.99 MA(250) :  128.27
MACD MACD :  -3.7 Signal :  -2.7
%K %D K(14,3) :  23.1 D(3) :  24.5
RSI RSI(14): 32.9
52-week High :  155.35 Low :  96.8
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ A ] has closed above bottom band by 30.4%. Bollinger Bands are 104.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 10 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 133.2 - 133.87 133.87 - 134.42
Low: 128.49 - 129.2 129.2 - 129.78
Close: 129.53 - 130.64 130.64 - 131.55
Company Description

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Headline News

Fri, 14 Jun 2024
Biopharma Layoff Tracker 2024: Barinthus, Agilent, BMS and More Cut Staff - BioSpace

Thu, 13 Jun 2024
Agilent Technologies Inc. stock falls Thursday, underperforms market - MarketWatch

Wed, 12 Jun 2024
Agilent Technologies Inc. stock rises Wednesday, still underperforms market - MarketWatch

Wed, 12 Jun 2024
Agilent Technologies, Inc. (NYSE:A) SVP Dominique Grau Sells 15,000 Shares - MarketBeat

Wed, 12 Jun 2024
Agilent Technologies executive sells $1.99 million in stock By Investing.com - Investing.com

Tue, 11 Jun 2024
Agilent Technologies, Bay Area company worth $38 billion, lays off 184 workers - SFGATE

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 292 (M)
Shares Float 291 (M)
Held by Insiders 0.2 (%)
Held by Institutions 92.3 (%)
Shares Short 4,240 (K)
Shares Short P.Month 4,120 (K)
Stock Financials
EPS 4.21
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 21.3
Profit Margin 18.8 %
Operating Margin 23.7 %
Return on Assets (ttm) 7.8 %
Return on Equity (ttm) 20.7 %
Qtrly Rev. Growth -8.4 %
Gross Profit (p.s.) 0
Sales Per Share 22.58
EBITDA (p.s.) 5.51
Qtrly Earnings Growth 2.9 %
Operating Cash Flow 1,900 (M)
Levered Free Cash Flow 924 (M)
Stock Valuations
PE Ratio 30.94
PEG Ratio 5.1
Price to Book value 6.12
Price to Sales 5.78
Price to Cash Flow 20.05
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android